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Lutropin (LH) directs ovulation and implantation by regulating the production of estrogen and progesterone. We have shown that the circulatory half-life of LH is controlled by the Man/GalNAc-4-SO4
receptor, which binds GalNAc-4-SO4 on LH oligosaccharides. The short half-life in conjunction with
episodic release of LH from the pituitary accounts for the pulsatile rise and fall in circulating LH.
Complete genetic ablation of the Man/GalNAc-4-SO4 receptor results in death in utero. Heterozygous female mice clear LH from the circulation more slowly and have smaller litters due to a reduction in the rate of implantation. This reduction is fully correctable by exogenous progesterone and
estrogen, indicating that the rate of LH clearance is critical for the production of sufficient progesterone and estrogen for implantation. Thus, the Man/GalNAc-4-SO4 receptor regulates the
endocrinological status of the female and is essential for an early event in embryonic development.
J. Clin. Invest. 109:269–276 (2002). DOI:10.1172/JCI200213997.

Introduction
Ovulation, fertilization, and implantation are complex
processes that depend on the exquisitely coordinated
interaction of neurons in the hypothalamus,
gonadotroph cells in the anterior pituitary, and target
cells in the ovary. These three participants form the
gonad/pituitary/hypothalamic axis. Abnormalities in
the regulation of this axis can result in infertility and
miscarriage (1–3). Peptide-releasing factors produced in
the hypothalamus stimulate gonadotroph cells to release
the glycoprotein hormones follitropin (FSH) and
lutropin (LH) into the circulation. FSH directs follicular
development and oocyte maturation, whereas LH is
responsible for the rupture of antral follicles to release
the ovum and for the conversion of postovulatory follicles into corpora lutea (4). The precisely controlled production of estrogen and progesterone, initially by developing follicles and subsequently by corpora lutea, is
essential for differentiation of the uterus into a receptive
state for the fertilized egg and for implantation (5–9).
LH characteristically demonstrates an episodic rise and
fall in the circulation that is critical for the biologic activity of LH in vivo. Gonadotropin-releasing hormone–
stimulated release of LH from dense core granules in
pituitary gonadotrophs generates these pulses at specific intervals. The amplitude and frequency of LH pulses
produced in the circulation are in turn regulated by
progesterone and estrogen levels (10–14). The pulsatile
rise and fall in circulating LH levels results in the episodThe Journal of Clinical Investigation
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ic stimulation of the LH receptor, a G protein–coupled
receptor (15). Episodic stimulation may be critical
because the activated form of the LH receptor is recognized by β-arrestin, resulting in uncoupling from adenylyl cyclase and internalization of the occupied receptor
(16). Replenishment at the cell surface with unoccupied
LH receptor requires periods between pulses when the
cells are not exposed to the hormone.
The episodic rise and fall in LH levels also requires that
LH have a short half-life in the circulation. The circulatory half-life of LH, but not FSH, is precisely controlled
by the Man/GalNAc-4-SO4 receptor that we have identified in hepatic endothelial cells (17, 18). We initially
demonstrated that LH bears unique oligosaccharide
structures that terminate with β1,4-linked GalNAc-4SO4 whereas FSH bears structures that terminate with
sialic acid linked to galactose (19–21). We have shown
that it is the cysteine-rich domain located at the aminoterminus of the Man/GalNAc-4-SO4 receptor, expressed
at high levels in hepatic endothelial cells, that specifically binds terminal β1,4-linked GalNAc-4-SO4 located on
the N-linked oligosaccharides of LH (22–24). This binding mediates the rapid clearance of LH from the circulation. The Man/GalNAc-4-SO4 receptor expressed by
hepatic endothelial cells is present in the form of a dimer
that must simultaneously bind to two terminal GalNAc4-SO4 moieties on LH to achieve the apparent Kd of
1.6 × 10–7 M we have observed with isolated cells (25).
The bound hormone is internalized and rapidly trans-
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ported to lysosomes where it is degraded. Each endothelial cell in rat liver expresses 600,000 receptors at the cell
surface (18), and it has been estimated that the half-time
for internalization of the surface pool of receptor-ligand
complexes is 10.1 seconds (26). We have calculated that
there is sufficient receptor to mediate the clearance of
LH from the blood with the t1/2 of 7.5 minutes observed
for clearance in the rat (17). Furthermore, only changes
in receptor level and/or the rate of internalization from
the cell surface are predicted to have an effect on the rate
of LH clearance from the blood.
We have generated mice expressing reduced levels of
the Man/GalNAc-4-SO4 receptor in order to examine the
role of LH clearance rate on follicle development, ovulation, and implantation. While animals homozygous
(–/–) for genetic ablation of the Man/GalNAc-4-SO4
receptor do not survive in utero, mice heterozygous (+/–)
for ablation of the receptor are normal. Female mice, but
not male mice, that are heterozygous for deletion of the
receptor display sufficient alterations in the regulation
of their endocrinologic state to markedly reduce the efficiency of implantation, but not ovulation.

Methods
Generation of Man/GalNAc-4-SO4 receptor–deficient mice by
gene targeting. A 129/SvJ BAC library (Genome Systems
Inc., St. Louis, Missouri, USA) was screened with a probe
derived from the cysteine-rich domain of the murine
Man/GalNAc-4-SO4 receptor cDNA. An 8-kb PstI fragment containing exon 2 encoding the cysteine-rich
domain of the receptor was isolated. The targeting vector was constructed by subcloning the fragment into
pZero (Invitrogen Corp., Carlsbad, California, USA).
Exon 2 of the Man/GalNAc-4-SO4 receptor was deleted
by inverse PCR with primers containing NotI sites at
their 5′ ends: 5′TTCCATCTGCGGCCGCTTGTGATCTTCATTATTAGATTAAAAATTG3′ and 5′GATCACAAGCGGCCGCAGATGGAAGGTCTATGGAACCACGGATGAC3′. A cassette containing the neomycin phosphotransferase
cDNA driven by the phosphoglycerate kinase promoter
(PGK-neo) flanked by loxP sites was inserted into the
NotI site created during deletion of exon 2 (Figure 1a).
Embryonic stem (ES) cells were electroporated with the
targeting plasmid that had been linearized with SnaBI.
Homologous recombination occurred in 22 of 140 ES
cell clones surviving selection with G418 that were analyzed by Southern blotting. Two colonies were individually injected into C57BL/6J blastocysts. Chimeric
males were mated with C57BL/6J females, and the first
generation of agouti offspring were screened by Southern blot analysis of tail genomic DNA for germline
transmission of the targeted allele. Genotypes of the
mice from later generations were determined by multiplex PCR using the primers P1: 5′GGGACCACTCAAGGATATGTT3′; P2: 5′GCTCTAAGTGCCATCTCAGTT3′; P3:
5′TGCTCGACGTTGTCACTGAAG3′; and P4: 5′CTCGTCAAGAAGGCGATAGAA3′. The expected sizes for the
wild-type and mutated alleles were 412 bp and 548 bp,
respectively (Figure 1).
270
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Analysis of ovulation and implantation. The number of
ovulated oocytes released during the estrous cycle was
determined by sacrificing female Man/GalNAc-4-SO4+/+
(M/G4S-R+/+) and M/G4S-R+/– mice the morning following estrus. The enlarged, translucent ampulla of each
oviduct was excised and trimmed, and the ovulated
oocyte-cumulus complexes were collected into a Petri
dish by washing with Dulbecco’s PBS. The oocytes were
then manually counted. Normal implantation was
examined by housing M/G4S-R+/+ and M/G4S-R+/–
female mice in estrus with M/G4S-R+/+ male mice
overnight. The morning of finding a vaginal plug was
designated day 1 of pregnancy. Implantation sites were
visualized on day 5 by intravenous injection of 0.1 ml
of Chicago sky blue 6B dye (Sigma Chemical Co., St.
Louis, Missouri, USA) (8). Exogenous hormone was
administered to M/G4S-R+/– females as follows: day 3 of
pregnancy at 0900 hours, progesterone (P4) (2 mg per
mouse); day 4 of pregnancy at 0900 hours, P4 (2 mg per
mouse) + 17β-estradiol (E2) (10 ng per mouse). Implantation sites were counted on day 5. P4 and E2 were dissolved in peanut oil and injected subcutaneously (0.1
ml/ per mouse). Mice without implantation sites were
not included in the analyses.
Quantitation of Man/GalNAc-4-SO4 receptor steady state
mRNA levels. Total RNA was isolated using TRIzol
reagent (Life Technologies Inc., Rockville, Maryland,
USA). Three micrograms of total RNA was used to synthesize the first-strand cDNA with Superscript II
RNaseH-Reverse Transcriptase (Life Technologies Inc.).
Quantitative PCR was performed on a LightCycler
(Roche Molecular Biochemicals, Indianapolis, Indiana,
USA) in a total volume of 20 µl of 10× reaction buffer
(Taq polymerase, deoxynucleoside triphosphates,
(MgCl2, SYBR Green I; Roche Molecular Biochemicals)
and 1 µl of first-strand cDNA. Ten pmol of each primer
(5′TGGGGACCTGGCAAGTAT3′ and 5′TGTCACTGGGGTTCCATC3′) was added. Real-time PCR was performed in
glass capillaries with an initial denaturation step of 2
minutes at 95°C, followed by 50 cycles of 0 seconds at
95°C, 10 seconds at 60°C, and 20 seconds at 72°C. At
the end of each cycle the fluorescence emitted by SYBR
Green was measured at 85°C. The PCR products from
tissue with the most abundant message were detected
after 35 cycles. A dilution series of Man/GalNAc-4-SO4
receptor cDNA of known concentration was included in
each run to generate a standard curve. Duplicate samples
for each analysis were quantified according to the LightCycler analysis software.
Detection of Man/GalNAc-4-SO4 receptor protein expression.
Livers from M/G4S-R+/+ and M/G4S-R+/– mice were
homogenized with a Polytron homogenizer (Brinkmann
Instruments, Westbury, New York, USA) in 5 volumes of
buffer containing 25 mM HEPES, 50 mM KCl, 2 mM
Mg acetate, 1 mM DTT, and 10% sucrose. Homogenates
were layered over a 65% sucrose cushion and sedimented at 100,000 g for 75 minutes. The membrane fraction
was collected and resuspended in 20 mM Tris, pH 7.8,
150 mM NaCl using a Dounce homogenizer. Protein
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Figure 1
Generation of Man/GalNAc-4-SO4 receptor+/– mice. (a) The
Man/GalNAc-4-SO4 receptor targeting construct. The 5′ and 3′
homologies were derived from exon 2, which encodes the entire cysteine-rich domain of the receptor, and its flanking introns. Exon 2 was
replaced with a PGK-neo cassette. (b) DNA from the live progeny of
heterozygous matings was genotyped by PCR or Southern blotting.
The wild-type locus was detected using primers P1 and P2, which
yielded a 421-bp product, and the mutant locus using primers P3 and
P4, which yielded a 548-bp product. No Man/GalNAc-4-SO4 receptor–/–
animals lived to birth. Examples of PCR reactions from M/G4S-R+/+
and M/G4S-R+/– mice are shown. Std, oligonucleotide standard.

concentrations were determined using the Bradford
method (Bio-Rad Laboratories, Hercules, California,
USA). Binding assays were performed with SO4-4-GalNAcβ1,4GlcNAcβ1,4Man-[125I]BSA (S4GGnM-BSA)
and [125I]asialo-orosomucoid (ASOR) in the presence of
1% Triton X-100 as described previously (22, 27).
Clearance studies were performed as described previously (17) in mice anesthetized with ketamine (87
mg/kg) and xylazine (13 mg/kg) by cannulating both
jugular veins. Mice were heparinized and 2 × 106 disintegrations per minute of [125I]bLH (1 µCi/10 ng LH) in
100 µl of saline was injected through the right jugular
vein. Samples were withdrawn from the left jugular
vein and weighed, and the amount of [125I]bLH present
per 50 µl was determined by γ-counting.

Results
Man/GalNAc-4-SO4 receptor–deficient mice. The role of LH
clearance by the Man/GalNAc-4-SO4 receptor was examined by preparing mice deficient in receptor. The targeting construct was prepared by replacing exon 2 with
a PGK-neo cassette (Figure 1). Exon 2 was chosen
because it encodes the entire cysteine-rich domain of
the Man/GalNAc-4-SO4 receptor and contains the
longest contiguous coding sequence, 413 bp (28). The
targeting vector was introduced into 129/SvJ ES cells by
electroporation and G418-resistant ES clones selected.
The Journal of Clinical Investigation
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Southern blot analysis identified 22 recombinants out
of 140 screened. Chimeric male mice were bred to
C57BL/6J females to generate heterozygous male and
female mice on a mixed background.
Wild-type (M/G4S-R+/+) and heterozygous (M/G4S-R+/–)
male mice were bred with M/G4S-R+/+ and M/G4S-R+/–
female mice. The M/G4S-R+/– × M/G4S-R+/+ crosses both
yielded the expected 1:1 ratio of M/G4S-R+/+ and
M/G4S-R+/– progeny (Table 1). In contrast, M/G4S-R+/– ×
M/G4S-R+/– breedings yielded M/G4S-R+/+ : M/G4S-R+/–
progeny in a ratio of 1:2.27 but did not yield any live animals homozygous (–/–) for the deletion (Table 1). Analyses of the embryos in utero indicated that loss of
M/G4S-R–/– embryos occurred prior to day 6.5 (not
shown). The results were not affected by the sex of the
M/G4S-R+/– mice used in the breedings.
Female mice heterozygous for deletion of the Man/GalNAc4-SO4 receptor have reduced litter sizes due to reduced
implantation. When females heterozygous for deletion
of the Man/GalNAc-4-SO4 receptor were bred with
either M/G4S-R+/+ or M/G4S-R+/– males, there was a
marked reduction of the median number of pups per
litter to five from the eight to nine obtained when
M/G4S-R+/+ or M/G4S-R+/– males were bred to
M/G4S-R+/+ females (Figure 2). Furthermore, only
15–20% of the litters born to M/G4S-R+/– females fell
within the normal range of litter size for M/G4S-R+/+
females (Figure 2). The majority of litters delivered by
M/G4S-R+/– females contained only 1–5 pups. We also
noted that the number of pups per litter delivered by
individual M/G4S-R+/– females tended to remain constant through multiple breedings. Since the reduction
in litter size is only seen when female mice are heterozygous for Man/GalNAc-4-SO4 receptor deletion,
this reduction reflects an alteration in the reproductive endocrinologic status of the female rather than a
defect in the development of the embryo. While a
greater reduction in litter size would be predicted for
the M/G4S-R+/– × M/G4S-R+/– cross than for the
M/G4S-R+/+ × M/G4S-R+/– cross due to the lethality of
the homozygous deletion, the difference between the
respective mean values of 4.7 and 5.2 for litter sizes
was not significant.
M/G4S-R+/– mice are predicted to express a reduced
number of Man/GalNAc-4-SO4 receptors in their
hepatic endothelial cells and clear LH from their circulation more slowly than M/G4S-R+/+ mice. Since LH regulates the production of estrogen and progesterone in
Table 1
No live M/G4S-R–/– mice are obtained from M/G4S-R+/– × M/G4S-R–/–
matings
Mating

Female +/+

Female +/–

Phenotypes of live progeny
+/+ : +/– : –/–
29:35:0
27:30:0

Male +/+
Male +/–

January 2002

|

Volume 109

|

Number 2
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79:180:0

271

Downloaded on June 2, 2013. The Journal of Clinical Investigation. More information at www.jci.org/articles/view/13997

Figure 2
Female mice heterozygous for deletion of the Man/GalNAc-4-SO4
receptor have smaller numbers of pups per litter. M/G4S-R+/+ and
M/G4S-R+/– female mice were bred with both M/G4S-R+/+ and
M/G4S-R+/– male mice. The number of pups born was determined the
morning of delivery. There was no apparent difference in appearance
or survival rate following delivery. Bars indicate the median value for
each group. Mean values of 4.7 (n = 63) for female M/G4S-R+/– × male
M/G4S-R+/–, 5.2 (n = 25) for female M/G4S-R+/– × male M/G4S-R+/+,
9.0 (n = 11) for female M/G4S-R+/+ × male M/G4S-R+/–, and 9.8
(n = 20) for female M/G4S-R+/+ × male M/G4S-R+/+ pups per litter were
obtained. ANOVA analysis using Tukey’s multiple comparison test indicated that differences between the means of female M/G4S-R+/– × male
M/G4S-R+/– and female M/G4S-R+/– × male M/G4S-R+/+, or between
female M/G4S-R+/+ × male M/G4S-R+/– and female M/G4S-R+/+ × male
M/G4S-R+/+, were not significant (P > 0.05). Differences between the
means for either female M/G4S-R+/– × male M/G4S-R+/– or female
M/G4S-R+/– × male M/G4S-R+/+, and either female M/G4S-R+/+ × male
M/G4S-R+/– or female M/G4S-R+/+ × male M/G4S-R+/+, were
highly significant (P < 0.001).

the ovary, altered rates of clearance could have an
impact on ovulation, implantation, or maintenance of
the fetus and result in the changes shown in Figure 2.
The ovulation rate for M/G4S-R+/+ and M/G4S-R+/–
females was examined by counting the number of eggs
released (Figure 3a). The difference in the mean values
for the number of eggs released by M/G4S-R+/+ and
M/G4S-R+/– animals, 8.7 and 8.2, respectively, is not significant. This suggests that the levels of estrogen and
progesterone produced in response to the preovulatory surge of LH are sufficient for the normal number of
eggs to be released from the ovary. In contrast, there is
a significant difference in the number of embryos that
are able to implant (Figure 3b) in M/G4S-R+/+ as compared with M/G4S-R+/– female mice, with means of 8.7
and 5.1 embryos implanted, respectively.
Implantation occurs around midnight of day 4 following copulation. In addition to increasing levels of
progesterone, a transient increase in estrogen levels is
seen during the morning prior to implantation. Implantation does not occur in the absence of this transient rise
in estrogen levels. Exogenous progesterone will maintain
the blastula in a condition termed delayed implantation
until exogenous estrogen is provided (5–9). Heterozygous females were, therefore, given progesterone (P4) on
day 3, and P4 + 17β-estradiol (E2) on day 4, by injection.
272
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The number of embryos implanted was determined on
day 5 (Figure 3b). Providing exogenous progesterone and
estrogen increased the mean for the number of embryos
implanted in the M/G4S-R+/– female mice to 7.1, a value
not significantly different from that of the M/G4S-R+/+
female mice. A small number of animals treated with E2
alone on day 4 also showed an increased rate of implantation consistent with the known requirement for estrogen (data not shown). Since LH regulates the production
of progesterone and estrogen at this critical time for
implantation, it appears that, in females heterozygous
for ablation of the Man/GalNAc-4-SO4 receptor, there is
a sufficient alteration in the clearance rate for LH to have
an impact on postovulatory hormone production and
implantation but not on ovulation itself.
mRNA and protein levels are reduced in mice heterozygous
for Man/GalNAc-4-SO4 receptor gene deletion. The
Man/GalNAc-4-SO4 receptor is expressed in
macrophages as well as in hepatic endothelial cells (29).
In addition we have detected the Man/GalNAc-4-SO4
receptor at the tubulovesicular junction of sperm and
sertoli cells (Y. Mi and J.U. Baenziger, unpublished
observation). The phenotype of the M/G4S-R+/– mice
indicates that levels of the Man/GalNAc-4-SO4 receptor are sufficiently reduced in these animals to affect
the physiologic regulation of their hormones. Message
levels were therefore determined for lung
(macrophages), testis (sertoli cells, sperm, and
macrophages), spleen (macrophages), and liver
(endothelial cells and Kupffer cells) as shown in Figure
4. The primer pair utilized is specific for exon 7 of the
receptor. Levels of Man/GalNAc-4-SO4 receptor message containing exon 7 were reduced by at least half in
the tissues examined with the exception of the spleen.
Thus, message for the mutant form of the
Man/GalNAc-4-SO4 receptor does not appear to be
expressed, even though only exon 2 was deleted, and
there is no evidence of significant compensation in
Man/GalNAc-4-SO4 receptor message levels for the
wild-type allele in M/G4S-R+/– mice.
The amounts of GalNAc-4-SO4–specific binding activity in the membranes prepared from livers of M/G4S-R+/+
and M/G4S-R+/– mice were also compared (Figure 5). The
amount of S4GGnM-[125I]BSA bound per microgram of

Table 2
M/G4S-R+/+ mice remove LH from the circulation more rapidly than
M/G4S-R+/– mice
Phenotype

Half-life (min)

SD

SEM

n

0.29
0.81

0.14
0.36

4
5

Mean
+/+
+/–

0.48
2.04

Mice were heparinized and catheterized through the jugular veins. Following
injection of [125I]bLH, 50-µl samples of blood were withdrawn and cpm determined in a γ-counter. The results of clearance studies in four M/G4S-R+/+ and
five M/G4S-R+/– animals were analyzed as summarized here. The best fit was
obtained with a single-component exponential decay curve using Prism 2.0.
An unpaired t test indicated that the half-lives are significantly different for
M/G4S-R+/+ and M/G4S-R+/– mice, with a P value of 0.0036.
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predicted to have an effect on the clearance rate for LH in
vivo. The reduction in GalNAc-4-SO4–specific binding by
M/G4S-R+/– liver membranes indicated that the rate of LH
clearance from the circulation would likely be slower in
M/G4S-R+/– than in M/G4S-R+/+ mice. Differences in the
rates of clearance were observed upon injection of
[125I]bLH into M/G4S-R+/+ and M/G4S-R+/– mice, as shown
in Figure 6 and summarized from multiple studies in
Table 2. Nonlinear regression analyses performed using
Prism 2.0 indicated that the best fit was obtained with
parameters for single-component exponential decay. The
half-life of LH in the circulation was 0.47 minutes for
M/G4S-R+/+ and 2.04 minutes for M/G4S-R+/– mice (Table
2). Thus, LH clearance is fourfold slower in M/G4S-R+/–
mice than in M/G4S-R+/+ mice. The increased time spent
in the circulation results in the levels of LH remaining elevated for longer periods of time, with an apparent impact
on activation and deactivation of the LH receptor in the
ovary that is sufficient to alter the levels of E2 produced
at the time of implantation.

Figure 3
Female mice heterozygous for deletion of the Man/GalNAc-4-SO4
receptor ovulate normally but have a reduced rate of implantation. (a)
Eggs were collected from genotyped mice the morning following estrus
and counted. An unpaired t test indicated that the mean values of 8.2
for M/G4S-R+/– female mice and 8.7 for M/G4S-R+/+ female mice were
not significant (P = 0.40). (b) Genotyped mice were given subcutaneous injections of P4 (2 mg per mouse) on day 3, and P4 (2 mg per
mouse) + E2 (10 ng per mouse) on day 4. Mice were injected with
Chicago sky blue 6B in saline on day 5 shortly before sacrifice, and the
number of implantation sites demarcated as localized blue bands (8)
was counted. Bars indicate the median. ANOVA analysis using Tukey’s
multiple comparison test indicated that the difference between the
mean value of 5.1 for M/G4S-R+/– female mice and 8.6 for M/G4S-R+/+
female mice is significant (P < 0.05) whereas the difference between
the means of 7.1 for M/G4S-R+/– female mice treated with P4 and E2
and 8.6 for M/G4S-R+/+ female mice was not significant (P > 0.05).

membrane protein was significantly reduced in preparations from M/G4S-R+/– mice. The GalNAc-4-SO4–specific binding activity in membranes from M/G4S-R+/–
mice was 67% of that in membranes from M/G4S-R+/+
mice. This reduction in binding was not observed for
another carbohydrate-specific receptor, the asialoglycoprotein receptor, examined with ASOR as the ligand
(Figure 5). Thus, based on both message levels and binding activity in the liver, the amount of Man/GalNAc-4SO4 receptor expressed by hepatic endothelial cells of
M/G4S-R+/– mice is significantly reduced when compared with that of M/G4S-R+/+ mice.
The clearance of LH from the blood is slower in mice heterozygous for deletion of the Man/GalNAc-4-SO4 receptor gene. Alterations in the number of Man/GalNAc-4-SO4 receptors
expressed at the surface of hepatic endothelial cells are
The Journal of Clinical Investigation
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Discussion
The N-linked oligosaccharides on the four members
of the glycoprotein hormone family contribute to the
biologic function of these hormones at multiple levels. The carbohydrates are important for folding and
assembly, for secretion, and for providing sufficient
mass to prevent rapid filtration by the kidney (30–32).
However, most striking is the critical role played by
the unique sulfated carbohydrate structures found on
LH and thyrotropin (TSH). LH and TSH bear unique

Figure 4
Man/GalNAc-4-SO4 receptor message is reduced in M/G4S-R+/– mice
as compared with M/G4S-R+/+ mice. Total RNA was prepared from
the tissues indicated. Three micrograms of total RNA were used to
synthesize first-strand cDNA for each tissue. The amount of
Man/GalNAc-4-SO4 receptor message for identical inputs of total
RNA was quantitated by PCR on a LightCycler by comparison to
Man/GalNAc-4-SO4 receptor cDNA of known concentration using
the primers specific for exon 7. The values shown represent the mean
of two determinations in each case. The duplicates for each determination differed by less than 5%.

January 2002

|

Volume 109

|

Number 2

273

Downloaded on June 2, 2013. The Journal of Clinical Investigation. More information at www.jci.org/articles/view/13997

Figure 5
GalNAc-4-SO4–specific binding is reduced in membranes from
M/G4S-R+/– mice as compared with M/G4S-R+/+ mice. Membranes
were prepared from livers of three M/G4S-R+/+ and three M/G4S-R+/–
mice and tested for binding of S4GGnM-BSA by the Man/GalNAc-4SO4 receptor and ASOR by the asialoglycoprotein receptor in triplicate at three different concentrations of membranes. The results are
presented as cpm bound per microgram of membrane protein. The
difference between the mean of 31.3 cpm bound per microgram for
M/G4S-R+/+ mice and 20.8 cpm bound per microgram for M/G4S-R+/–
mice for S4GGnM-BSA was highly significant (P = 0.0009), whereas
the difference between the mean of 279 cpm bound per microgram
for M/G4S-R+/+ mice and 298 cpm bound per microgram for
M/G4S-R+/– mice for ASOR was not significant (P = 0.58).

N-linked oligosaccharides that terminate with β1,4linked GalNAc-4-SO4 (20, 21, 31, 33–35). In contrast,
the N-linked oligosaccharides FSH and chorionic
gonadotropin terminate with the sequence sialic acid
α2,3/6-galactose (20, 21, 36). The presence of this
unique carbohydrate modification on LH and TSH
reflects the action of a protein-specific β1,4-N-acetylgalactosaminyltransferase (37–40) and a recently
cloned GalNAc-4-sulfotransferase (41, 42). The sulfated carbohydrate structures synthesized by these
transferases are present on these glycoprotein hormones produced in the pituitaries of all vertebrate
species (43). Thus, the unique features of the N-linked
carbohydrate structures like those of the protein have
been conserved throughout vertebrate evolution,
indicating that they are of vital importance to the
action of LH in vivo. Our observation that LH bearing
oligosaccharides terminating with β1,4-linked
GalNAc-4-SO4 is rapidly cleared from the circulation
by a receptor we identified as the Man/GalNAc-4-SO4
receptor led us to propose that the rate of clearance is
critical for attaining optimal activation of ovarian LH
receptors in vivo (17, 30). The pulsatile rise and fall in
LH levels reflects stimulated release of LH from
gonadotrophs by gonadotropin-releasing hormone
and the short half-life due to Man/GalNAc-4-SO4
receptor binding and internalization. Notably, both
the amplitude and the frequency of LH pulses can be
modulated by P4 and E2 in vivo (11). The pulse frequency is considered particularly critical for the initi274
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ation of ovulation (44, 45). Furthermore, in humans
the episodic rise and fall in circulating LH levels first
appears during puberty and continues throughout
the reproductive years (11, 46).
The affinity of the Man/GalNAc-4-SO4 receptor for
LH, 1.7 × 10–7 M (18), and the number of receptors in
hepatic endothelial cells, 600,000 LH-binding sites per
cell (18), have been determined for the rat. The combination of this affinity and abundance of the
Man/GalNAc-4-SO4 receptor make it ideal for maintaining a specific rate of clearance at any LH concentration that falls within the physiologic range. LH levels in the circulation of the rat, 0.1 × 10–9 to 1.0 × 10–9
M, fall far below the Kd for binding to the
Man/GalNAc-4-SO4 receptor. However, the abundance
of the receptor at the endothelial cell surface and the
large number of endothelial cells present in the liver
together provide sufficient capacity to bind on the
order of 10% of the total pool of circulating LH if 0.5%
of the receptor sites are occupied. The Man/GalNAc-4SO4 receptor has one of the fastest rates of internalization measured to date for an endocytic receptor, with a
reported half-time of 10.1 seconds for internalization
of the entire pool of occupied receptor (26). As a result,
effectively all of the bound LH, representing 10% of the
total circulating pool of LH, will be internalized and
degraded every 30 seconds, yielding a predicted half-life
of 2.5 minutes for the rat. This prediction is in close
agreement with the half-lives we have measured in the
mouse, 0.48 minutes, and the rat, 7.5 minutes (17). An
important feature of this mechanism for LH clearance
is that the rate of clearance will remain constant at LH
concentrations below the Kd for binding to the receptor and will only be altered by a change in either the
number of Man/GalNAc-4-SO4 receptors expressed at
the cell surface or their rate of internalization. Thus,
the reduced number of receptors in M/G4S-R+/– mice

Figure 6
LH is cleared from the circulation more slowly by M/G4S-R+/– mice
than by M/G4S-R+/+ mice. [125I]bLH was injected into M/G4S-R+/– and
M/G4S-R+/+ mice, and 50 µl of blood was withdrawn from a cannula in the jugular vein at the times indicated. The amount of radioactivity in each sample was determined on a γ-counter. The curves
shown were generated with Prism 2.0 (GraphPad Software Inc., San
Diego, California, USA) using the equation for exponential decay
with a single component.
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should, as observed, result in an increase in the circulatory half-life of LH. Both the height and the width of
the LH pulse but not the level of LH between pulses
should be altered by a change in half-life. We have not,
however, been able to document changes in peak width
and height for LH pulses, because technical considerations including the amount of serum and the number
of samples required are prohibitive in mice.
Our present studies demonstrate that reducing the
levels of Man/GalNAc-4-SO4 receptor on hepatic
endothelial cells by roughly half increases the circulatory half-life of injected LH by fourfold. These studies
underscore the relationship of the Man/GalNAc-4-SO4
receptor and the terminal β1,4-linked GalNAc-4-SO4
moieties on LH to the regulation of P4 and E2 levels.
While the decrease in the clearance rate for LH in the
M/G4S-R+/– mice does not have an impact on the ovulation rate, the slower rate of clearance does affect
implantation. Implantation in the mouse occurs on
day 4 and requires a brief increase in E2 levels on day 3
(5, 7, 9). In the absence of this brief increase in E2 levels,
the blastocysts remain viable but dormant in a condition termed delayed implantation. Correction of the
implantation delay in the M/G4S-R+/– mice by providing exogenous P4 and E2 indicates that the decreased
rate of LH clearance in these heterozygotes is sufficient
to perturb the endocrinologic state of the female so
that inadequate levels of E2 are produced.
The regulation of LH levels and their relationship to
levels of P4 and E2 production in the context of the
gonad/pituitary/hypothalamic axis are complex. Elevated levels of circulating LH are associated with infertility
and miscarriage in humans. For example, women with
polycystic ovary syndrome exhibit continuous hypersecretion of LH. The reduced rate of implantation seen
in M/G4S-R+/– mice suggests that alterations in the rate
of internalization of the Man/GalNAc-4-SO4 receptor,
the affinity of the cysteine-rich domain for terminal
GalNAc-4-SO4, the ability of the receptor to form dimeric species, or the pattern of LH glycosylation could all
result in changes in the regulation of P4 and/or E2 production in response to LH. The levels of Man/GalNAc4-SO4 receptors in liver increase in response to E2 in mice
(ref. 47; and Y. Mi and J.U. Baenziger, unpublished observation). This is consistent with the observation that in
postmenopausal women the half-life for LH increases
from 57 minutes to 139 minutes (48). The change in
half-life may reflect changes in the level of Man/GalNAc4-SO4 receptor expression and in the levels of GalNAc-4SO4 addition to LH, which are also sensitive to E2 levels
(49). Such changes could contribute to the decline in fertility with increasing age.
The current studies provide a strong link between the
carbohydrate structures on LH, the Man/GalNAc-4SO4 receptor, and the regulation of E2 and P4 production in vivo. Furthermore, the phenotype of the
M/G4S-R+/– female demonstrates that the in vivo regulation of circulatory half-life for proteins may be of critical importance for biologic activity. The role of the
The Journal of Clinical Investigation
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Man/GalNAc-4-SO4 receptor during development of
the embryo represents a different function that
remains to be elucidated. Our studies emphasize that
the Man/GalNAc-4-SO4 receptor is multifunctional,
having at least two critical functions during the ovulatory cycle and development that are distinct from its
potential role in innate immunity as a mannose-specific receptor in macrophages (50, 51).
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